Dr. Jeffrey Miller Kenkel, MD

Dr. Kenkel practices at Plastic Surgery Clinic at UT Southwestern Medical Center - HOPD in Dallas, Texas.

Dr. Kenkel's NPI, 1427088905, was assigned on July 3, 2006. Dr. Kenkel graduated from Georgetown University School Of Medicine in 1989. Dr. Kenkel's Texas license number on file is K0861.

Dr. Kenkel's primary practice is Plastic Surgery Clinic at UT Southwestern Medical Center - HOPD, at 1801 Inwood Rd, Dallas, TX 75235.

Dr. Kenkel's primary practice is Plastic Surgery Clinic at UT Southwestern Medical Center - HOPD in Dallas, Texas. Dr. Kenkel is also affiliated with William P. Clements Jr. University Hospital. The medical group on file is University of Texas Southwestern Medical Center. Dmand AI also links Dr. Kenkel to 1 more group practice or clinic, named with a free account. Dr. Kenkel's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kenkel practices, 3 sites in all. Vendor and product names are available with a free account.

Plastic and reconstructive surgery is Dr. Kenkel's primary specialty in the NPI Registry, under taxonomy code 2086S0122X. Dr. Kenkel is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Kenkel's licenses on file in 7 states: Texas, Florida, California, Georgia, New York, Pennsylvania and District of Columbia.

CMS data shows 15 Medicare services from Dr. Kenkel across 1 procedure code in 2021, all of them office visits, for 13 Medicare patients. Medicare paid $591 for them. Every service was in an office.

CMS counts 13 Medicare patients who saw Dr. Kenkel in 2024. 75% of them have high cholesterol. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kenkel's median patient age at 64, with 67% women.

In 2024, Dr. Kenkel wrote 110 Medicare Part D claims for 34 patients. 99% of them were for generic drugs. CMS names the drug for 58 of them, across 4 drugs with 11 or more claims each, at $196 in total drug cost. In 2023, CMS named 80 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Kenkel for performance year 2024, reported as part of a group. Dr. Kenkel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 206 papers to Dr. Kenkel, published from 2004 to 2025. 2022 was the busiest year, with 10. The most frequent topics are Lipectomy, Cosmetic Techniques and Plastic Surgery Procedures. Dr. Kenkel has published most often in Aesthet Surg J. Dr. Kenkel's most frequent co-authors are Rodney J. Rohrich, MD, Samuel J. Beran, MD and Ryan Sami Constantine, MD.

Dmand AI links Dr. Kenkel to 10 clinical trials. Conditions studied include Cutis Laxa, Skin Diseases, Genetic and Hypertrophy. University of Texas Southwestern Medical Center sponsors the most, 5.

CMS Open Payments shows 165 general payments to Dr. Kenkel from 30 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 53% of the total. Galderma Laboratories, L.P. paid the most, $40,545.

Dmand AI lists 5 awards for Dr. Kenkel, most recently America's Top Doctors in 2014.

Dr. Kenkel graduated from Georgetown University School Of Medicine in 1989. Dr. Kenkel is a member of ACS and ASPS.

Dr. Kenkel is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.